0.248

3.80% -0.0098

After Hours: .25 0.002 +0.81%

China Pharma Holdings Inc. (CPHI)

Overview News Price History Discussions Forecast Stock Split

China Pharma Holdings Inc. stock is traded at $0.248, with a volume of 267.32K. It is down -3.80% in the last 24 hours and down -0.36% over the past month. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Previous Close:

$0.2578

Open:

$0.2455

24h Volume:

267.32K

Relative Volume:

0.83

Market Cap:

$4.29M

Revenue:

$7.78M

Net Income/Loss:

$-3.11M

P/E Ratio:

-0.5167

EPS:

-0.48

Net Cash Flow:

$-72,500

1W Performance:

-2.90%

1M Performance:

-0.36%

6M Performance:

-22.09%

1Y Performance:

-47.84%

1-Day Range:

$0.2411

$0.2597

1-Week Range:

$0.2403

$0.2637

52-Week Range:

$0.17

$1.1575

China Pharma Holdings Inc. Stock (CPHI) Company Profile

Name

China Pharma Holdings Inc.

Sector

Healthcare (1182)

Industry

Drug Manufacturers - Specialty & Generic (85)

Phone

86 898 6681 1730

Address

No. 17, Jinpan Road, Second Floor, Haikou

Employee

276

Twitter

Next Earnings Date

Latest SEC Filings

CPHI's Discussions on Twitter

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-10	Initiated	Rodman & Renshaw	Mkt Outperform

China Pharma Holdings Inc. Stock (CPHI) Latest News

Nov 01, 2024

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat

Oct 29, 2024

Oct 28, 2024

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

Oct 28, 2024

Oct 22, 2024

RRJ Buys $150 Million Luye Bonds, First China Deal Since 2019 - BNN Bloomberg

Oct 22, 2024

Oct 21, 2024

Insiders of China Medical System Holdings Limited (HKG:867) must be disappointed as stock fell 4.7% after recent purchases - Simply Wall St

Oct 21, 2024

AI Redefines the Pharmaceuticals Wholesale and Distribution Market, Projected to Grow by USD 896.5 Billion from 2024-2028, Boosting Global Sales - The Malaysian Reserve

Oct 21, 2024

Oct 13, 2024

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com - Defense World

Oct 13, 2024

Oct 10, 2024

China Constipation Treatment Drug Industry Growth Factors, Applications, and Forecast by (2024-2034) - IndiaPolitics.com

Oct 10, 2024

Oct 09, 2024